Ownership

Thomas Andrew Crockett - CEO, Director at KalVista Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: CEO, Director
Stock Symbol: KALV on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Thomas Andrew Crockett - trading volume in the past year for KalVista Pharmaceuticals, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-138K	100%	$13.56	-$1.87M
Net	-138K	-100%		-$1.87M

Holdings reported by Thomas Andrew Crockett for KalVista Pharmaceuticals, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	211K	$2.98M	$14.11	Feb 20, 2024	Direct
Performance Stock Units	62.5K	$938K	$15.01	Feb 17, 2024	Direct	Common Stock
Restricted Stock Unit	48.6K	$730K	$15.01	Feb 17, 2024	Direct	Common Stock
Performance Stock Unit	0		$8.23	Nov 17, 2023	Direct	Common Stock

Transactions reported by Thomas Andrew Crockett for KalVista Pharmaceuticals, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.